Tagged with “FDA”

More Leucovorin Woes

A September 2nd update from the FDA cites manufacturing delays at Bedford Laboratories and Teva Pharmaceuticals for leucovorin shortages.

Here at the Colorectal Cancer Coalition, we’re hearing from patients who are not receiving leucovorin during their chemotherapy because it just isn’t available.

Bedford says that they will be releasing some 350 mg and 200 mg vials in September and are working on other presentations. Teva is allocating 100 mg vials and says that the 350 mg vials are on back-order with an expected release date in the fourth quarter of 2010. Continue reading…

Posted by Kate Murphy on September 2nd, 2010
Posted in: Research & Treatment News | 1 Comment »
Tags: FDA, leucovorin shortage

Four-Fold Increase In Salmonella Infections Traced to One Egg Producer

Check the eggs in your refrigerator!

The FDA, collaborating with the Centers for Disease Control, the Department of Agriculture, and state health departments, have traced a nationwide spike in Salmonella Enteritidis (SE) infections to a single firm in Iowa.

Eggs shipped from Wright County Egg of Galt, Iowa after May 16,2010 have been recalled.

The CDA received approximately 200 reports of Salmonella Enteritidis every week in late June and early July, more than four times the usual 50 weekly reports over the past five years. Continue reading…

Posted by Kate Murphy on August 19th, 2010
Posted in: Research & Treatment News | No Comments »
Tags: CDC, egg recall, FDA, salmonella

Miracle Mineral Solution Can Cause Serious Harm

The FDA has warned the public that Miracle Mineral Solution (MMS) makes a dangerous, industrial strength bleach when mixed as directed and can cause serious health problems.

High oral doses of this bleach, such as those recommended in the labeling, can cause nausea, vomiting, diarrhea, and symptoms of severe dehydration.

FDA recommends

Consumers who have MMS should stop using it immediately and throw it away. The FDA advises consumers who have experienced any negative side effects from MMS to consult a health care professional as soon as possible. Continue reading…

Posted by Kate Murphy on August 2nd, 2010
Posted in: Research & Treatment News | No Comments »
Tags: FDA, Medwatch, Miracle Mineral Solution

House Appropriations Subcommittee Approves Increase in Funding for the FDA

Today, the House Appropriations Agriculture Subcommittee met to consider the fiscal year 2011 bill that funds the Food and Drug Administration (FDA). The Subcommittee approved $2.571 billion in funding for the FDA.

This is an increase of $214 million above last year’s level and $55 million above the President’s request. C3 is very pleased with this proposed increase, and applauds the leadership of Chairwoman De Lauro, Ranking Member Kingston and the members of the Subcommittee.

Earlier this month, C3 advocates went to Capitol Hill to urge Congress to increase funding for the FDA. Register today as a C3 advocate, and we will update you on what you can do to help us make sure this increased funding for the FDA stays in the bill as it moves through the appropriations process.

Posted by Catherine Knowles on June 30th, 2010
Posted in: Policy & Advocacy News | No Comments »
Tags: Appropriations, Commissioner Hamburg, Congressman Hinchey, Congressman Kingston, Congresswoman DeLauro, Congresswoman Emerson, FDA, FY 2011, Senator Grassley

C3 Advocates Head to Capitol Hill

During meetings today with their Senators and Representatives, C3 advocates will be sharing their personal stories and urging Congress to make federal funding for cancer a top priority.

C3′s Grassroots Action Committee Chair Pam Seijo, Grassroots Action Committee Members Florence Kurttila, Arlene Murphy, and Ed Murphy, along with C3 advocates Patti Hollenback, Cindy Robinson, and Regan Weaver are all participating in the annual One Voice Against Cancer (OVAC) Lobby Day.

Posted by Catherine Knowles on June 17th, 2010
Posted in: C3 News, Policy & Advocacy News | No Comments »
Tags: Appropriations, CDC, FDA, NCI, NIH, OVAC